COSTANZO, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 107
EU - Europa 101
AS - Asia 79
SA - Sud America 11
AF - Africa 2
Totale 300
Nazione #
US - Stati Uniti d'America 105
RU - Federazione Russa 54
SG - Singapore 40
CN - Cina 24
BR - Brasile 9
DE - Germania 9
HK - Hong Kong 9
IT - Italia 7
NL - Olanda 7
FI - Finlandia 6
UA - Ucraina 5
FR - Francia 4
GB - Regno Unito 3
PL - Polonia 3
VN - Vietnam 3
IE - Irlanda 2
ZA - Sudafrica 2
AR - Argentina 1
CA - Canada 1
EC - Ecuador 1
ID - Indonesia 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
SE - Svezia 1
Totale 300
Città #
Singapore 19
Chandler 17
Moscow 10
Hong Kong 9
Beijing 8
Amsterdam 7
Jacksonville 7
Santa Clara 6
Falls Church 5
Los Angeles 5
Millbury 5
Munich 5
Wilmington 5
Ashburn 4
Nanjing 3
Princeton 3
São Paulo 3
Turku 3
Brooklyn 2
Cernusco sul Naviglio 2
Dallas 2
Naples 2
Warsaw 2
Albany 1
Arraial do Cabo 1
Bexley 1
Brasília 1
Buffalo 1
Changsha 1
Chicago 1
Cirebon 1
Detroit 1
Fortaleza 1
Haiphong 1
Huế 1
Hưng Yên 1
Indiana 1
Itamaraju 1
Johannesburg 1
Kuala Lumpur 1
Lanús 1
Magé 1
Mexico City 1
Nanchang 1
Orange Park 1
Ottawa 1
Quito 1
Salt Lake City 1
Seattle 1
Stockholm 1
Tampa 1
Tianjin 1
Tokyo 1
Vila Velha 1
Wroclaw 1
Yuncheng 1
Totale 167
Nome #
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. 122
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 91
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. 90
Totale 303
Categoria #
all - tutte 1.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 1 4 1 0 1 0 3 0
2021/202230 0 0 0 0 2 4 1 0 4 3 8 8
2022/202335 5 3 3 3 1 4 0 3 4 9 0 0
2023/202416 0 4 4 0 2 2 0 1 0 0 2 1
2024/2025106 6 12 1 1 5 1 8 6 2 9 46 9
2025/202682 18 8 25 19 12 0 0 0 0 0 0 0
Totale 303